Acknowledgments
We thank the staff of Neuroscience Publications at Barrow Neurological Institute for assistance with manuscript and video preparation.
Funding
This study did not receive any funding or financial support.
Disclosures
Dr Tumialán is an investor in LessRay, which was acquired by NuVasive as well as DuraStat, TrackX, and Fusion Robotics. The other authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.